Guided Therapeutics (GTHP) EBIT Margin Growth (3y) (2013 - 2025)
Guided Therapeutics (GTHP) EBIT Margin Growth (3y) (2013 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -343.00 |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 17.00 |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 78.00 |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 487.00 |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -283.00 |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 1,505.00 |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 2,016.00 |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -184.00 |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Guided Therapeutics | 21.96 Mn | 21.89 Mn | 458,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 4.00 Mn |
| Jun 30, 2025 | 1.37 Mn |
| Dec 31, 2024 | -5.27 Mn |
| Dec 31, 2023 | -36,362.00 |
| Sep 30, 2022 | -2.20 Mn |
| Jun 30, 2022 | 1.84 Mn |
| Mar 31, 2022 | -743,222.00 |
| Dec 31, 2021 | 34,405.00 |
| Sep 30, 2021 | 913,684.00 |
| Jun 30, 2021 | -2.19 Mn |
| Dec 31, 2020 | -46,882.00 |
| Sep 30, 2020 | 385,887.00 |
| Dec 31, 2019 | -126,047.00 |
| Sep 30, 2019 | -1.81 Mn |
| Dec 31, 2018 | 1.61 Mn |
| Sep 30, 2018 | 1.13 Mn |
| Jun 30, 2018 | 987,250.00 |
| Mar 31, 2018 | 52,000.00 |
| Dec 31, 2017 | 1.58 Mn |
| Sep 30, 2017 | 691,970.00 |